513 related articles for article (PubMed ID: 37217354)
41. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
[TBL] [Abstract][Full Text] [Related]
42. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
43. [Predictive factors for lymph node metastasis in patients with poorly differentiated early gastric cancer].
Pang BR; Zhu ZL; Li C; Liu WT; KumarSah RD; Yan M; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):446-450. PubMed ID: 31104430
[No Abstract] [Full Text] [Related]
44. Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification.
Endo S; Dousei T; Yoshikawa Y; Hatanaka N; Taniyama K; Yamauchi A; Kamiike W; Nishijima J
Int Surg; 2012; 97(4):335-9. PubMed ID: 23294075
[TBL] [Abstract][Full Text] [Related]
45. [Analysis of clinicopathological features and prognosis of 142 cases with synchronous multiple gastric carcinoma].
Qi LK; Yuan XH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):620-3. PubMed ID: 27531483
[TBL] [Abstract][Full Text] [Related]
46. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
[TBL] [Abstract][Full Text] [Related]
47. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
Özaslan E; Demir S; Karaca H; Güven K
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
[TBL] [Abstract][Full Text] [Related]
49. Mixed neuroendocrine non-neuroendocrine neoplasm of the gallbladder complicated by a pancreaticobiliary maljunction of a non-dilated biliary duct: A case report.
Wagatsuma K; Akita K; Motoya M; Kimura Y; Sugita S; Hirano T; Kawakami Y; Numata Y; Ishigami K; Masaki Y; Murota A; Shitani M; Akutsu N; Sasaki S; Nakase H
Medicine (Baltimore); 2021 Oct; 100(39):e27336. PubMed ID: 34596138
[TBL] [Abstract][Full Text] [Related]
50. Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.
Ishida S; Akita M; Fujikura K; Komatsu M; Sawada R; Matsumoto H; Saegusa J; Itoh T; Kakeji Y; Zen Y
Hum Pathol; 2021 Apr; 110():1-10. PubMed ID: 33359239
[TBL] [Abstract][Full Text] [Related]
51. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
[No Abstract] [Full Text] [Related]
52. Colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and PD-L1 expression.
Ho YH; Hsu CY; Yau Li AF; Liang WY
Hum Pathol; 2024 Mar; 145():80-85. PubMed ID: 38423221
[TBL] [Abstract][Full Text] [Related]
53. [Effect of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio on prognosis of patients with gastric cancer].
Han BL; Wang YM; Xue YW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):65-70. PubMed ID: 31958933
[No Abstract] [Full Text] [Related]
54. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
55. Differences in clinicopathology and prognosis between gastroesophageal junctional and gastric non-cardiac neuroendocrine carcinomas: a retrospective comparison study of consecutive 56 cases from a single institution in China.
Cheng Y; Zhang X; Zhou X; Xu K; Lin M; Huang Q
Am J Cancer Res; 2022; 12(10):4737-4750. PubMed ID: 36381336
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine tumors: analysis from a single-institution.
Zeng YJ; Liu L; Wu H; Lai W; Cao JZ; Xu HY; Wang J; Chu ZH
Asian Pac J Cancer Prev; 2013; 14(10):5775-81. PubMed ID: 24289577
[TBL] [Abstract][Full Text] [Related]
57. Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease.
Matrood S; Apostolidis L; Schrader J; Krug S; Lahner H; Ramaswamy A; Librizzi D; Kender Z; Kröcher A; Kreutzfeldt S; Gress TM; Rinke A
Front Endocrinol (Lausanne); 2021; 12():709256. PubMed ID: 34690926
[TBL] [Abstract][Full Text] [Related]
58. [Analysis of primary site and pathology on 903 patients with neuroendocrine neoplasms].
Qiu X; Liu M; Liu Q; Yang Z; Liu J; Meng F; Wang Z; Shi Y; Liu L; Zhang P; Luo J; Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):993-996. PubMed ID: 28900988
[TBL] [Abstract][Full Text] [Related]
59. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
60. Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems.
Yang M; Ke NW; Zhang Y; Zeng L; Tan CL; Zhang H; Mai G; Tian BL; Liu XB
Medicine (Baltimore); 2015 Dec; 94(48):e2156. PubMed ID: 26632896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]